Case number 1:22-cv-01462
Amicus Therapeutics US, LLC et al v. Teva Pharmaceutical Industries Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 7, 2023 | N/A | Remark: The parties should follow the Court's Standing Order Regarding Courtesy Copies, a copy of which is found on Judge Burkes portion of the District Court's webpage: https://www.ded.uscourts.gov/sites/ded/files/CJBCC2022.pdf Associated Cases: 1:22-cv-01461-CJB, 1:22-cv-01462-CJB, 1:22-cv-01465-CJB, 1:22-cv-01467-CJB(dlb) (Entered: 06/07/2023) (0) |
| Jun 7, 2023 | N/A | REMARK: The parties should be aware that the Court encourages the participation of newer attorneys in courtroom proceedings and at oral argument. Please see the Court's Standing Order Regarding Courtroom Opportunities for Newer Attorneys, a link to which is provided here for the parties' convenience:http://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrder2017.pdf Associated Cases: 1:22-cv-01461-CJB, 1:22-cv-01462-CJB, 1:22-cv-01465-CJB, 1:22-cv-01467-CJB(dlb) (Entered: 06/07/2023) (0) |
| Jun 6, 2023 | 30 | CONSENT to Jurisdiction by U.S. Magistrate Judge filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc.. Case reassigned to Magistrate Judge Christopher J. Burke. Signed by Judge Colm F. Connolly on 6/6/2023. (nmf) (Entered: 06/06/2023) (1) |
| May 19, 2023 | N/A | Case associated with lead case: Create association to 1:22-cv-01461-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 22-1461-CFC ONLY. (nmf) (Entered: 05/19/2023) (0) |
| May 19, 2023 | 29 | SCHEDULING & CONSOLIDATION ORDER: CIVIL ACTION NO. 22-1461-CFC SHALL BE THE LEAD CASE AND ALL FUTURE FILINGS SHALL BE MADE IN THE LEAD CASE ONLY. Joinder of Parties due by 3/28/2024. Amended Pleadings due by 3/28/2024. Fact Discovery completed by 6/27/2024. Expert Discovery due by 1/16/2025. Joint Claim Construction Brief due by 3/7/2024. A Markman Hearing is set for 5/1/2024 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 3/5/2025. A Final Pretrial Conference is set for 3/26/2025 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 4/7/2025 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 5/18/2023. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01465-CFC, 1:22-cv-01467-CFC(nmf) (Entered: 05/19/2023) (30) |
| May 15, 2023 | 28 | PROPOSED ORDER // [Proposed] Scheduling Order by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A)(Stover, Chad) (Entered: 05/15/2023) (Main Document) (26) |
| May 15, 2023 | 28 | PROPOSED ORDER // [Proposed] Scheduling Order by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A)(Stover, Chad) (Entered: 05/15/2023) (Exhibit A) (4) |
| May 9, 2023 | 27 | Official Transcript of In-Person Scheduling Conference held on May 8, 2023 before Chief Judge Connolly. Court Reporter/Transcriber Bonnie Archer, Email: Bonnie_Archer@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 5/30/2023. Redacted Transcript Deadline set for 6/9/2023. Release of Transcript Restriction set for 8/7/2023. (nmf) (Entered: 05/09/2023) (0) |
| May 8, 2023 | N/A | Minute Entry for proceedings held before Judge Colm F. Connolly - Scheduling Conference held on 5/8/2023. (Court Reporter Bonnie Archer.) Counsel shall submit a revised proposed scheduling order to the Court on or before May 15, 2023. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01465-CFC, 1:22-cv-01467-CFC(nmf) (Entered: 05/08/2023) (0) |
| Apr 27, 2023 | N/A | ORAL ORDER Setting Scheduling Conference:( An In-Person Scheduling Conference is set for 5/8/2023 at 02:30 PM in Courtroom 4B before Judge Colm F. Connolly. Ordered by Judge Colm F. Connolly on 4/27/2023. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01465-CFC, 1:22-cv-01467-CFC(nmf) (Entered: 04/27/2023) (0) |
| Apr 25, 2023 | N/A | Pro Hac Vice Attorney Kurt A. Mathas and Tyree M. Petty-Williams for Teva Pharmaceuticals USA, Inc. and Teva Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC(mpb) (Entered: 04/25/2023) (0) |
| Apr 24, 2023 | N/A | SO ORDERED, re 26 MOTION for Pro Hac Vice Appearance of Attorney Kurt Mathas and Tyree M. Petty-Williams, filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc. Ordered by Judge Colm F. Connolly on 4/24/2023. (kmd) (Entered: 04/24/2023) (0) |
| Apr 19, 2023 | 26 | MOTION for Pro Hac Vice Appearance of Attorney Kurt Mathas and Tyree M. Petty-Williams - filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc.. (Keller, Karen) (Entered: 04/19/2023) (5) |
| Apr 18, 2023 | 25 | PROPOSED ORDER regarding Scheduling Order by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Letter regarding Proposed Scheduling Order)(Stover, Chad) (Entered: 04/18/2023) (Letter regarding Proposed Scheduling Order) (2) |
| Apr 18, 2023 | 25 | PROPOSED ORDER regarding Scheduling Order by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Letter regarding Proposed Scheduling Order)(Stover, Chad) (Entered: 04/18/2023) (Main Document) (30) |
| Apr 10, 2023 | N/A | SO ORDERED, re (34 in 1:22-cv-01467-CFC) STIPULATION TO EXTEND TIME to Submit Proposed Scheduling Order to April 18, 2023 filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC, (28 in 1:22-cv-01465-CFC) STIPULATION TO EXTEND TIME to Submit Proposed Scheduling Order to April 18, 2023 filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC, (24 in 1:22-cv-01462-CFC) STIPULATION TO EXTEND TIME to Submit Proposed Scheduling Order to April 18, 2023 filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC, (24 in 1:22-cv-01461-CFC) STIPULATION TO EXTEND TIME to Submit Proposed Scheduling Order to April 18, 2023 filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC. Signed by Judge Colm F. Connolly on 4/10/2023. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01465-CFC, 1:22-cv-01467-CFC(nmf) (Entered: 04/10/2023) (0) |
| Apr 7, 2023 | 24 | STIPULATION TO EXTEND TIME to Submit Proposed Scheduling Order to April 18, 2023 - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Stover, Chad) (Entered: 04/07/2023) (3) |
| Feb 17, 2023 | 23 | ANSWER to 12 Answer to Complaint, Counterclaim by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc..(Stover, Chad) (Entered: 02/17/2023) (30) |
| Feb 10, 2023 | 22 | Letter to The Honorable Colm F. Connolly from Chad S.C. Stover regarding coordinated discovery and Markman proceedings - re (14 in 1:22-cv-01462-CFC, 14 in 1:22-cv-01462-CFC, 22 in 1:22-cv-01465-CFC, 22 in 1:22-cv-01465-CFC, 14 in 1:22-cv-01461-CFC, 14 in 1:22-cv-01461-CFC, 18 in 1:22-cv-01467-CFC, 18 in 1:22-cv-01467-CFC) Order,,, Set Deadlines,,. (Stover, Chad) (Entered: 02/10/2023) (2) |
| Jan 25, 2023 | 21 | SO ORDERED, re 20 STIPULATION TO EXTEND TIME to Respond to Counterclaims to February 17, 2023, filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC. Reset Answer Deadlines: Amicus Therapeutics US, LLC answer due 2/17/2023; Amicus Therapeutics, Inc. answer due 2/17/2023. Signed by Judge Colm F. Connolly on 1/25/2023. (kmd) (Entered: 01/25/2023) (3) |
| Jan 24, 2023 | 20 | STIPULATION TO EXTEND TIME to Respond to Counterclaims to February 17, 2023 - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Stover, Chad) (Entered: 01/24/2023) (3) |
| Jan 23, 2023 | 18 | SO ORDERED, re 16 STIPULATION and Covenant Not to Sue re: U.S. Patent Nos. 8,592,362, 9,095,584, 9,480,682, 10,525,045, 11,033,538, 11,241,422, 10,251,873, 10,471,053, 10,792,278, 10,799,491, 10,857,141, 10,857,142, and 10,874,656. Signed by Judge Colm F. Connolly on 1/23/2023. (nmf) (Entered: 01/23/2023) (8) |
| Jan 23, 2023 | 19 | SO ORDERED, re 17 STIPULATION and Covenant Not to Sue re: U.S. Patent Nos. 10,076,514 and 11,234,972. Signed by Judge Colm F. Connolly on 1/23/2023. (nmf) (Entered: 01/23/2023) (5) |
| Jan 20, 2023 | 16 | STIPULATION and Covenant Not to Sue re: U.S. Patent Nos. 8,592,362, 9,095,584, 9,480,682, 10,525,045, 11,033,538, 11,241,422, 10,251,873, 10,471,053, 10,792,278, 10,799,491, 10,857,141, 10,857,142, and 10,874,656 by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Stover, Chad) (Entered: 01/20/2023) (7) |
| Jan 20, 2023 | 17 | STIPULATION and Covenant Not to Sue re: U.S. Patent Nos. 10,076,514 and 11,234,972 by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Stover, Chad) (Entered: 01/20/2023) (5) |
| Jan 19, 2023 | 15 | MOTION for Pro Hac Vice Appearance of Attorney Daniel E. Orr - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Stover, Chad) (Entered: 01/19/2023) (4) |
| Jan 19, 2023 | N/A | SO ORDERED, re (23 in 1:22-cv-01465-CFC) (15 in 1:22-cv-01461-CFC) (19 in 1:22-cv-01467-CFC) (15 in 1:22-cv-01462-CFC) MOTION for Pro Hac Vice Appearance of Attorney Daniel E. Orr, filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC. Ordered by Judge Colm F. Connolly on 1/19/2023. Associated Cases: 1:22-cv-01465-CFC, 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01467-CFC(kmd) (Entered: 01/19/2023) (0) |
| Jan 18, 2023 | N/A | Pro Hac Vice Attorney Joshua E. Ney for Amicus Therapeutics US, LLC and Amicus Therapeutics, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01465-CFC, 1:22-cv-01467-CFC(mkr) (Entered: 01/18/2023) (0) |
| Jan 17, 2023 | N/A | Pro Hac Vice Attorney Lauren Baker for Amicus Therapeutics US, LLC and Amicus Therapeutics, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01465-CFC, 1:22-cv-01467-CFC(mpb) (Entered: 01/17/2023) (0) |
| Jan 12, 2023 | 14 | ORDER, IT IS ORDERED that, on or before February 10, 2023, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to these cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 2/10/2023.) Signed by Judge Colm F. Connolly on 1/12/2023. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01465-CFC, 1:22-cv-01467-CFC(nmf) (Entered: 01/12/2023) (3) |
| Jan 10, 2023 | N/A | Pro Hac Vice Attorneys John W. Cox, Joshua M. Kalb, Mark C. Nelson, Anna Whitacre for Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01465-CFC, 1:22-cv-01467-CFC(twk) (Entered: 01/10/2023) (0) |
| Jan 10, 2023 | N/A | Pro Hac Vice Attorney Christina M. Baugh for Amicus Therapeutics US, LLC and Amicus Therapeutics, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01465-CFC, 1:22-cv-01467-CFC(mpb) (Entered: 01/10/2023) (0) |
| Jan 6, 2023 | 13 | Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. filed by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc.. (Hoeschen, Nathan) (Entered: 01/06/2023) (2) |
| Jan 6, 2023 | 12 | ANSWER to 1 Complaint,, , COUNTERCLAIM against Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc. by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd..(Hoeschen, Nathan) (Entered: 01/06/2023) (30) |
| Dec 7, 2022 | N/A | SO ORDERED, re (11 in 1:22-cv-01462-CFC) (16 in 1:22-cv-01465-CFC) (11 in 1:22-cv-01461-CFC) (12 in 1:22-cv-01467-CFC) MOTION for Pro Hac Vice Appearance of Attorney John W. Cox, Ph.D., Mark C. Nelson, Christina M. Baugh, Josh E. Ney, Ph.D., Heather B. Repicky, Joshua M. Kalb, Lauren Baker and Anna Whitacre, filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC. Ordered by Judge Colm F. Connolly on 12/7/2022. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01465-CFC, 1:22-cv-01467-CFC(kmd) (Entered: 12/07/2022) (0) |
| Dec 7, 2022 | 11 | MOTION for Pro Hac Vice Appearance of Attorney John W. Cox, Ph.D., Mark C. Nelson, Christina M. Baugh, Josh E. Ney, Ph.D., Heather B. Repicky, Joshua M. Kalb, Lauren Baker and Anna Whitacre - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Stover, Chad) (Entered: 12/07/2022) (11) |
| Dec 6, 2022 | 10 | AFFIDAVIT of Service for Complaint served on counsel for Teva Pharmaceuticals USA, Inc. on 11/30/2022, filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Stover, Chad) (Entered: 12/06/2022) (2) |
| Nov 30, 2022 | N/A | SO ORDERED, re 9 STIPULATION TO EXTEND TIME for Defendants Teva Pharmaceuticals USA, Inc. and Teva Pharmaceuticals, Inc. to move, plead, or otherwise respond to the complaints to January 6, 2023, filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc. Reset Answer Deadlines: Teva Pharmaceuticals USA, Inc. answer due 1/6/2023; Teva Pharmaceuticals, Inc. answer due 1/6/2023. Ordered by Judge Colm F. Connolly on 11/30/2022. (kmd) (Entered: 11/30/2022) (0) |
| Nov 29, 2022 | 9 | STIPULATION TO EXTEND TIME for Defendants Teva Pharmaceuticals USA, Inc. and Teva Pharmaceuticals, Inc. to move, plead, or otherwise respond to the complaints to January 6, 2023 - filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc.. (Keller, Karen) (Entered: 11/29/2022) (2) |
| Nov 9, 2022 | N/A | Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01465-CFC, 1:22-cv-01467-CFC (rjb) (Entered: 11/09/2022) (0) |
| Nov 8, 2022 | 8 | SUMMONS Returned Executed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc..Teva Pharmaceuticals USA, Inc. served on 11/8/2022, answer due 11/29/2022. (Stover, Chad) (Entered: 11/08/2022) (2) |
| Nov 7, 2022 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4000350.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 11/07/2022) (Main Document) (30) |
| Nov 7, 2022 | 7 | Summons Issued as to Teva Pharmaceutical Industries Ltd. on 11/7/2022; Teva Pharmaceuticals USA, Inc. on 11/7/2022; Teva Pharmaceuticals, Inc. on 11/7/2022. (Attachments: # 1 Summons Issued, # 2 Summons Issued)(apk) (Entered: 11/07/2022) (Main Document) (2) |
| Nov 7, 2022 | 6 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Amicus Therapeutics US, LLC. (apk) (Entered: 11/07/2022) (2) |
| Nov 7, 2022 | 5 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Amicus Therapeutics, Inc. (apk) (Entered: 11/07/2022) (2) |
| Nov 7, 2022 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s)(SEE PATENT REPORT) (apk) (Entered: 11/07/2022) (2) |
| Nov 7, 2022 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice:(SEE ANDA FORM) Date of Expiration of Patent:(SEE ANDA FORM)Thirty Month Stay Deadline: 2/10/2026. (apk) (Entered: 11/07/2022) (3) |
| Nov 7, 2022 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) (Entered: 11/07/2022) (3) |
| Nov 7, 2022 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4000350.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 11/07/2022) (Exhibit A) (30) |
| Nov 7, 2022 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4000350.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 11/07/2022) (Exhibit B) (30) |
| Nov 7, 2022 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4000350.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 11/07/2022) (Exhibit C) (30) |
| Nov 7, 2022 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4000350.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 11/07/2022) (Exhibit D) (30) |
| Nov 7, 2022 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4000350.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 11/07/2022) (Exhibit E) (30) |
| Nov 7, 2022 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4000350.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 11/07/2022) (Exhibit F) (30) |
| Nov 7, 2022 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4000350.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 11/07/2022) (Exhibit G) (30) |
| Nov 7, 2022 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4000350.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 11/07/2022) (Exhibit H) (30) |
| Nov 7, 2022 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4000350.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 11/07/2022) (Exhibit I) (30) |
| Nov 7, 2022 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4000350.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 11/07/2022) (Exhibit J) (30) |
| Nov 7, 2022 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4000350.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 11/07/2022) (Exhibit K) (30) |
| Nov 7, 2022 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4000350.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 11/07/2022) (Exhibit L) (30) |
| Nov 7, 2022 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4000350.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 11/07/2022) (Exhibit M) (30) |
| Nov 7, 2022 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4000350.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 11/07/2022) (Exhibit N) (30) |
| Nov 7, 2022 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4000350.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 11/07/2022) (Exhibit O) (30) |
| Nov 7, 2022 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4000350.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 11/07/2022) (Exhibit P) (30) |
| Nov 7, 2022 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4000350.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 11/07/2022) (Exhibit Q) (30) |
| Nov 7, 2022 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4000350.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 11/07/2022) (Exhibit R) (30) |
| Nov 7, 2022 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4000350.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 11/07/2022) (Exhibit S) (30) |
| Nov 7, 2022 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4000350.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 11/07/2022) (Exhibit T) (30) |
| Nov 7, 2022 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4000350.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 11/07/2022) (Exhibit U) (30) |
| Nov 7, 2022 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4000350.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 11/07/2022) (Exhibit V) (30) |
| Nov 7, 2022 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4000350.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 11/07/2022) (Exhibit W) (30) |
| Nov 7, 2022 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4000350.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 11/07/2022) (Civil Cover Sheet) (2) |
| Nov 7, 2022 | 7 | Summons Issued as to Teva Pharmaceutical Industries Ltd. on 11/7/2022; Teva Pharmaceuticals USA, Inc. on 11/7/2022; Teva Pharmaceuticals, Inc. on 11/7/2022. (Attachments: # 1 Summons Issued, # 2 Summons Issued)(apk) (Entered: 11/07/2022) (Summons Issued) (2) |
| Nov 7, 2022 | 7 | Summons Issued as to Teva Pharmaceutical Industries Ltd. on 11/7/2022; Teva Pharmaceuticals USA, Inc. on 11/7/2022; Teva Pharmaceuticals, Inc. on 11/7/2022. (Attachments: # 1 Summons Issued, # 2 Summons Issued)(apk) (Entered: 11/07/2022) (Summons Issued) (2) |
